Application Note from OMICs Hub Metabolomics

APPLICATION NOTE from the OMICs HUB about inter-individual heterogeneity in clinical metabolomics studies: Assessment of inter-individual NMR/MS metabolic signatures variability in plasma of a heterogeneous group of healthy volunteers –...

Registrations still opened for I4ID 2019!

Don’t forget to register to the next I4ID 2019 congress! Registrations to the 3rd Immunotherapies & Innovation for Infectious Diseases (I4ID2019) are still opened. The congress will be held on...

BIOASTER obtains certification NGO Source

BIOASTER, the Technology Research Institute (TRI) gives itself the means to develop new partnerships with American foundations invested in the fight against infectious diseases. The BIOASTER Foundation received an “Equivalency...

New collaboration with LNC Therapeutics about Microbiome

BIOASTER announces a collaboration with LNC Therapeutics, a leading biotech in the development of innovative microbiome-based therapies, located in Bordeaux, France. The aim of the partnership is to support LNC...

Next edition #3 I4ID Congress

The next edition of I4ID Congress #3 will take place on December 4th and 5th, 2019 in Lyon France.